Literature DB >> 16545361

The vertebrate spalt genes in development and disease.

Dylan Sweetman1, Andrea Münsterberg.   

Abstract

The spalt proteins are encoded by a family of evolutionarily conserved genes found in species as diverse as Drosophila, C. elegans and vertebrates. In humans, mutations in some of these genes are associated with several congenital disorders which underscores the importance of spalt gene function in embryonic development. Recent studies have begun to cast light on the functions of this family of proteins with increasing understanding of the developmental processes regulated and the molecular mechanisms used. Here we review what is currently known about the role of spalt genes in vertebrate development and human disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545361     DOI: 10.1016/j.ydbio.2006.02.009

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  48 in total

1.  Sall4 regulates neuromesodermal progenitors and their descendants during body elongation in mouse embryos.

Authors:  Naoyuki Tahara; Hiroko Kawakami; Katherine Q Chen; Aaron Anderson; Malina Yamashita Peterson; Wuming Gong; Pruthvi Shah; Shinichi Hayashi; Ryuichi Nishinakamura; Yasushi Nakagawa; Daniel J Garry; Yasuhiko Kawakami
Journal:  Development       Date:  2019-07-15       Impact factor: 6.868

2.  Sall3 is required for the terminal maturation of olfactory glomerular interneurons.

Authors:  Susan J Harrison; Mark Parrish; A Paula Monaghan
Journal:  J Comp Neurol       Date:  2008-04-10       Impact factor: 3.215

3.  DNA-binding and regulatory properties of the transcription factor and putative tumor suppressor p150(Sal2).

Authors:  Hongcang Gu; Dawei Li; Chang K Sung; Hyungshin Yim; Philip Troke; Thomas Benjamin
Journal:  Biochim Biophys Acta       Date:  2011-03-31

Review 4.  Kidney regeneration and resident stem cells.

Authors:  Scott Reule; Sandeep Gupta
Journal:  Organogenesis       Date:  2011-04-01       Impact factor: 2.500

5.  Sall1 is a transcriptional regulator defining microglia identity and function.

Authors:  Anne Buttgereit; Iva Lelios; Xueyang Yu; Melissa Vrohlings; Natalie R Krakoski; Emmanuel L Gautier; Ryuichi Nishinakamura; Burkhard Becher; Melanie Greter
Journal:  Nat Immunol       Date:  2016-10-24       Impact factor: 25.606

6.  ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state.

Authors:  Yakov Chudnovsky; Dohoon Kim; Siyuan Zheng; Warren A Whyte; Mukesh Bansal; Mark-Anthony Bray; Shuba Gopal; Matthew A Theisen; Steve Bilodeau; Prathapan Thiru; Julien Muffat; Omer H Yilmaz; Maya Mitalipova; Kevin Woolard; Jeongwu Lee; Riko Nishimura; Nobuo Sakata; Howard A Fine; Anne E Carpenter; Serena J Silver; Roel G W Verhaak; Andrea Califano; Richard A Young; Keith L Ligon; Ingo K Mellinghoff; David E Root; David M Sabatini; William C Hahn; Milan G Chheda
Journal:  Cell Rep       Date:  2014-01-16       Impact factor: 9.423

Review 7.  Functional and clinical significance of SALL4 in breast cancer.

Authors:  Ebubekir Dirican; Mustafa Akkiprik
Journal:  Tumour Biol       Date:  2016-07-21

8.  Development of the Proximal-Anterior Skeletal Elements in the Mouse Hindlimb Is Regulated by a Transcriptional and Signaling Network Controlled by Sall4.

Authors:  Katherine Q Chen; Naoyuki Tahara; Aaron Anderson; Hiroko Kawakami; Sho Kawakami; Ryuichi Nishinakamura; Pier Paolo Pandolfi; Yasuhiko Kawakami
Journal:  Genetics       Date:  2020-03-10       Impact factor: 4.562

9.  Expression and clinical significance of SALL4 and β-catenin in colorectal cancer.

Authors:  Liliang Hao; Yan Zhao; Zhen Wang; Hongzhuan Yin; Xin Zhang; Tao He; Shanshan Song; Shaolong Sun; Baosheng Wang; Zhijie Li; Qi Su
Journal:  J Mol Histol       Date:  2016-01-16       Impact factor: 2.611

10.  Genetic screening of 202 individuals with congenital limb malformations and requiring reconstructive surgery.

Authors:  D Furniss; S-H Kan; I B Taylor; D Johnson; P S Critchley; H P Giele; A O M Wilkie
Journal:  J Med Genet       Date:  2009-05-07       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.